Ilya Pharma

Ilya Pharma AB

Ilya Pharma was founded in 2016, is headquartered in Uppsala, Sweden, lists 11–50 employees, and has $13.7M in recorded funding across 3 rounds.

Headquarters
Uppsala
Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$13.7M
Last Round
$9.8M Series BMar 2022
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Ilya Pharma is a Swedish biopharmaceutical company, founded in 2016 out of research at Uppsala University, developing next-generation local-acting immunotherapies and biologic drugs to treat wounds in skin and mucosa. Its lead program, ILP100, uses engineered lactic acid bacteria to deliver the therapeutic protein CXCL12 directly to wound sites to accelerate healing, and has advanced through Swedish Medical Products Agency-approved clinical trials.

Summary

Ilya Pharma is a Biotech company based in Uppsala, Sweden, founded in 2016. It lists 11–50 employees. It has raised $13.7M in total across 3 rounds, most recently a $9.8M Series B round in Mar 2022. Investors include European Innovation Council Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMar 2022
$9.8M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ilya Pharma on Indexed.vc
<a href="https://indexed.vc/companies/ilya-pharma"><img src="https://indexed.vc/api/badge/company/ilya-pharma" alt="Ilya Pharma on Indexed.vc" width="260" height="76" /></a>